Table 2.
Individual surgery details and follow-up of the 25 patients enrolled in the study.
| Patients | Gender, age (years) | Time to recurrence from OLT (months) | Nodules: number/size (mm) | PET scan | Resection | Lobe | Surgical access | ICU | Blood trasfusion | Surgery complications, type | HCC recurrence after surgery | Time of recurrence from surgery (months) | Site of recurrence after surgery | Polmonary surgery for recurrence | Follow-up (months) | Dead |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #1 | Male, 62 | 92 | 1/18 | Pos | WEDGE | LUL | VATS | No | No | No | Yes | 8.7 | Abdomen | No | 50 | No |
| #2 | Male, 57 | 57 | 1/NA | NA | MWA | LUL | VATS | No | No | No | ** | NA | NA | NA | 39 | Yes |
| #3 | Male, 58 | 13 | 1/13 | Neg | WEDGE | RLL | VATS | No | No | No | Yes | 4.1 | Lung | No | 97 | No |
| #4 | Female, 60 | 34 | 1/NA | Pos | WEDGE | RUL | VATS | No | No | Yes, wound infection/dehiscence | No | NA | NA | NA | 16 | No |
| #5 | Male, 61 | 18 | 1/12 | Neg | WEDGE | LLL | VATS | No | No | No | ** | NA | NA | NA | 26 | Yes |
| #6 | Male, 58 | 25 | 1/5 | Neg | WEDGE | RLL | VATS | No | No | No | Yes | 20.9 | Lung | Yes | 39 | Yes |
| #7 | Male, 41 | 9 | 3/NA | NA | WEDGE | RLL, RUL | Thoracotomy | No | Yes | Yes, haemothorax | Yes | 9.2 | Multifocal | No | 31 | Yes |
| #8 | Male, 51 | 13 | 1/17 | Neg | WEDGE | LUL | VATS | No | No | No | Yes | 16.3 | Liver | No | 29 | Yes |
| #9 | Male, 53 | 15 | 1/4 | Pos | WEDGE | RUL | Thoracotomy | No | No | No | No | NA | NA | NA | 23 | No |
| #10 | Male, 60 | 9 | 2/8 | NA | WEDGE | LLL | VATS | No | No | No | Yes | 5.3 | Bone | No | 7 | No |
| #11 | Female, 43 | 36 | 3/7 | Pos | WEDGE | LLL | Thoracotomy | No | No | No | Yes | 2.1 | Lung | Yes | 213 | No |
| #12 | Female, 71 | 306 | 2/4 | Pos | WEDGE | RLL | Thoracotomy | Yes,3 days | No | Yes, acute renal failure | No | NA | NA | NA | 19 | No |
| #13 | Male, 62 | 62 | 1/12 | Neg | SEGMENTECTOMY | RLL | VATS | No | Yes | Yes, haemothorax | No | NA | NA | NA | 8 | No |
| #14 | Male, 68 | 42 | 1/17 | Neg | WEDGE | LLL | VATS | No | No | No | Yes | 1.5 | Multifocal | No | 47 | No |
| #15 | Male, 64 | 1 | 1/10 | NA | WEDGE | LUL | VATS | No | No | No | Yes | 23.7 | Multifocal | No | 33 | Yes |
| #16 | Male, 68 | 8 | 1/13 | NA | WEDGE | RLL | VATS | No | No | No | No | NA | NA | NA | 32 | No |
| #17 | Male, 49 | 6 | 2/12 | NA | WEDGE | RLL | VATS | No | No | No | No | NA | NA | NA | 32 | No |
| #18 | Male, 51 | 51 | 1/33 | Pos | WEDGE | ML | Thoracotomy | No | No | No | Yes | 14.5 | Multifocal | No | 21 | Yes |
| #19 | Male, 68 | 36 | 2/15 | Pos | WEDGE | LLL, LUL | Thoracotomy | No | No | No | Yes | 15 | Lung | No | 51 | Yes |
| #20 | Male, 70 | 67 | 1/14 | Neg | LOBECTOMY | ML | VATS | No | No | No | Yes | 5.3 | Liver | No | 57 | No |
| #21 | Male, 56 | 50 | 1/6 | Neg | WEDGE | RLL | VATS | No | No | No | No | NA | NA | NA | 36 | No |
| #22 | Male, 52 | 14 | 1/22 | Pos | WEDGE | RLL | Thoracotomy | No | No | No | Yes | 32.6 | Lung | Yes | 35 | No |
| #23 | Male, 53 | 20 | 1/13 | Pos | WEDGE | RLL | Thoracotomy | No | No | No | No | NA | NA | NA | 12 | No |
| #24 | Male, 58 | 46 | 3/15 | Neg | WEDGE | LLL | VATS | No | No | No | No | NA | NA | NA | 18 | No |
| #25 | Male, 73 | 121 | 2/15 | Pos | WEDGE | LLL | Thoracotomy | No | No | No | No | NA | NA | NA | 6 | No |
LLL, left lower lobe; LUL, left upper lobe; PET, positron emission tomography; LM, median lobe; RLL, right lower lobe; RUL, right upper lobe; ICU, intensive care unit.
VATS, video-assisted thoracic surgery; MWA, percutaneous microwave ablation;
**
Diagnostic surgery; Pos, positive; Neg, negative; NA, not available or not applicable.